FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1508713024> ?p ?o ?g. }

• W1508713024 endingPage "E788" @default.
• W1508713024 startingPage "E783" @default.
• W1508713024 abstract "What's known on the subject? and What does the study add? Over-treatment of indolent prostate cancer lesions is a problem which can result in increased human and medical costs. Lesions with a low suspician level at mpMRI of the prostate have low risk of including high risk prostate cancer.To determine whether multiparametric magnetic resonance imaging (mpMRI) has the potential to identify patients at low risk for cancer, thus obviating the need for biopsy. Prostate cancer is currently diagnosed by random biopsies, resulting in the discovery of multiple low-risk cancers that often lead to overtreatment.We reviewed 800 consecutive patients who underwent a 3 Tesla mpMRI of the prostate with an endorectal coil from March 2007 to November 2011. All suspicious lesions were independently reviewed by two radiologists using T2-weighted, diffusion-weighted, spectroscopic and dynamic contrast-enhanced MRI sequences. Patients with only low suspicion lesions (maximum of two positive parameters on mpMRI) who subsequently underwent transrectal ultrasonography (TRUS)/MRI fusion targeted biopsy were selected for analysis.In total, 125 patients with only low suspicion prostatic lesions on mpMRI were identified. On TRUS/MRI fusion biopsy, 77 (62%) of these patients had no cancer detected, 38 patients had Gleason 6 disease and 10 patients had Gleason 7 (3+4) disease. There were 30 patients with cancer detected on biopsy who qualified for active surveillance using 2011 National Comprehensive Cancer Network guidelines. No cases of high-risk (≥ Gleason 4+3) cancer were identified on biopsy and, of the fifteen patients who underwent radical prostatectomy at our institution, none were pathologically upgraded to high-risk cancer. Thus, for patients with only low suspicion lesions, 107 (88%) patients either had no cancer or clinically insignificant disease.The results obtained in the present study show that low suspicion lesions on mpMRI are associated with either negative biopsies or low-grade tumours suitable for active surveillance. Such patients have a low risk of harbouring high-risk prostate cancers." @default.
• W1508713024 created "2016-06-24" @default.
• W1508713024 creator A5019280982 @default.
• W1508713024 creator A5022455023 @default.
• W1508713024 creator A5038850729 @default.
• W1508713024 creator A5056148509 @default.
• W1508713024 creator A5060683840 @default.
• W1508713024 creator A5068001843 @default.
• W1508713024 creator A5068012456 @default.
• W1508713024 creator A5079028607 @default.
• W1508713024 creator A5079411632 @default.
• W1508713024 creator A5081694111 @default.
• W1508713024 creator A5082080836 @default.
• W1508713024 date "2012-11-06" @default.
• W1508713024 modified "2023-10-14" @default.
• W1508713024 title "Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer" @default.
• W1508713024 cites W1974962780 @default.
• W1508713024 cites W1977308437 @default.
• W1508713024 cites W1980404552 @default.
• W1508713024 cites W1983635239 @default.
• W1508713024 cites W1998282791 @default.
• W1508713024 cites W2002522522 @default.
• W1508713024 cites W2021063134 @default.
• W1508713024 cites W2029761145 @default.
• W1508713024 cites W2032778875 @default.
• W1508713024 cites W2039994695 @default.
• W1508713024 cites W2045862330 @default.
• W1508713024 cites W2057296538 @default.
• W1508713024 cites W2092989749 @default.
• W1508713024 cites W2103444700 @default.
• W1508713024 cites W2105386786 @default.
• W1508713024 cites W2124539070 @default.
• W1508713024 cites W2141198296 @default.
• W1508713024 cites W2148844122 @default.
• W1508713024 cites W2156505206 @default.
• W1508713024 cites W2158734599 @default.
• W1508713024 cites W2165034249 @default.
• W1508713024 doi "https://doi.org/10.1111/j.1464-410x.2012.11646.x" @default.
• W1508713024 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3808160" @default.
• W1508713024 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23130821" @default.
• W1508713024 hasPublicationYear "2012" @default.
• W1508713024 type Work @default.
• W1508713024 sameAs 1508713024 @default.
• W1508713024 citedByCount "94" @default.
• W1508713024 countsByYear W15087130242013 @default.
• W1508713024 countsByYear W15087130242014 @default.
• W1508713024 countsByYear W15087130242015 @default.
• W1508713024 countsByYear W15087130242016 @default.
• W1508713024 countsByYear W15087130242017 @default.
• W1508713024 countsByYear W15087130242018 @default.
• W1508713024 countsByYear W15087130242019 @default.
• W1508713024 countsByYear W15087130242020 @default.
• W1508713024 countsByYear W15087130242021 @default.
• W1508713024 countsByYear W15087130242022 @default.
• W1508713024 countsByYear W15087130242023 @default.
• W1508713024 crossrefType "journal-article" @default.
• W1508713024 hasAuthorship W1508713024A5019280982 @default.
• W1508713024 hasAuthorship W1508713024A5022455023 @default.
• W1508713024 hasAuthorship W1508713024A5038850729 @default.
• W1508713024 hasAuthorship W1508713024A5056148509 @default.
• W1508713024 hasAuthorship W1508713024A5060683840 @default.
• W1508713024 hasAuthorship W1508713024A5068001843 @default.
• W1508713024 hasAuthorship W1508713024A5068012456 @default.
• W1508713024 hasAuthorship W1508713024A5079028607 @default.
• W1508713024 hasAuthorship W1508713024A5079411632 @default.
• W1508713024 hasAuthorship W1508713024A5081694111 @default.
• W1508713024 hasAuthorship W1508713024A5082080836 @default.
• W1508713024 hasBestOaLocation W15087130241 @default.
• W1508713024 hasConcept C121608353 @default.
• W1508713024 hasConcept C126322002 @default.
• W1508713024 hasConcept C126838900 @default.
• W1508713024 hasConcept C143409427 @default.
• W1508713024 hasConcept C146357865 @default.
• W1508713024 hasConcept C151730666 @default.
• W1508713024 hasConcept C2775934546 @default.
• W1508713024 hasConcept C2776235491 @default.
• W1508713024 hasConcept C2779466945 @default.
• W1508713024 hasConcept C2780002838 @default.
• W1508713024 hasConcept C2780192828 @default.
• W1508713024 hasConcept C2781217009 @default.
• W1508713024 hasConcept C2910607126 @default.
• W1508713024 hasConcept C71924100 @default.
• W1508713024 hasConcept C86803240 @default.
• W1508713024 hasConceptScore W1508713024C121608353 @default.
• W1508713024 hasConceptScore W1508713024C126322002 @default.
• W1508713024 hasConceptScore W1508713024C126838900 @default.
• W1508713024 hasConceptScore W1508713024C143409427 @default.
• W1508713024 hasConceptScore W1508713024C146357865 @default.
• W1508713024 hasConceptScore W1508713024C151730666 @default.
• W1508713024 hasConceptScore W1508713024C2775934546 @default.
• W1508713024 hasConceptScore W1508713024C2776235491 @default.
• W1508713024 hasConceptScore W1508713024C2779466945 @default.
• W1508713024 hasConceptScore W1508713024C2780002838 @default.
• W1508713024 hasConceptScore W1508713024C2780192828 @default.
• W1508713024 hasConceptScore W1508713024C2781217009 @default.
• W1508713024 hasConceptScore W1508713024C2910607126 @default.
• W1508713024 hasConceptScore W1508713024C71924100 @default.
• W1508713024 hasConceptScore W1508713024C86803240 @default.

• next